Polpharma Biologics and MS Pharma partner to expand biosimilar access
Deal covers biosimilars for gastroenterology, neurology and dermatology Deal covers biosimilars for gastroenterology, neurology and dermatology
Previous Post
Telangana Medical Council Raid unearths 4 clinics operated by 5 Quacks
Next Post
Ionis looks to expand use of lipid-lowering drug after trial hits goal
📢
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago